These HMGB1-enriched sEVs promoted keratinocyte proliferation and the secretion of proinflammatory cytokines such as IL-6, likely facilitating cholesteatoma progression through the activation of the MAPK p44/p42, STAT3, and NF-κB signalling pathways [81]. This evidence concerns the gene HMGB1 and cholesteatoma.